First Biosimilar Insulin, Glargine, Approved in EUFirst Biosimilar Insulin, Glargine, Approved in EU

The European Commission has approved an insulin glargine product from Lilly and Boehringer Ingelheim, a so-called biosimilar of Sanofi's insulin glargine, a basal insulin. International Approvals
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Diabetes & Endocrinology News Alert Source Type: news